The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Corticosteroids for preventing relapse following acute exacerbations of asthma
Open accessAbstract
BACKGROUND: Acute asthma is responsible for many emergency department (ED) visits annually. Between 12 to 16% will relapse to require additional interventions within two weeks of ED discharge. Treatment of acute asthma is based on rapid reversal of bronchospasm and reducing airway inflammation. OBJECTIVES: To determine the benefit of corticosteroids (oral, intramuscular, or intravenous) for the treatment of asthmatic patients discharged from an acute care setting (i.e. usually the emergency department) after assessment and treatment of an acute asthmatic exacerbation. SEARCH STRATEGY: We searched the Cochrane Airways Group Specialised Register and reference lists of articles. In addition, authors of all included studies were contacted to locate unpublished studies. The most recent search was run in October 2006. SELECTION CRITERIA: Randomized controlled trials comparing two types of corticosteroids (oral, intra-muscular, or inhaled) with placebo for outpatient treatment of asthmatic exacerbations in adults or children. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed trial quality and extracted data. Study authors were contacted for additional information. MAIN RESULTS: Six trials involving 374 people were included. One study used intramuscular corticosteroids, five studies used oral corticosteroids. The review was split into two reviews and although the latest search yielded no additional placebo controlled trials an additional IM study was included. Significantly fewer patients in the corticosteroid group relapsed to receive additional care in the first week (Relative risk (RR) 0.38; 95% confidence interval (CI) 0.2 to 0.74). This favourable effect was maintained over the first 21 days (RR 0.47; 95% CI 0.25 to 0.89) and there were fewer subsequent hospitalizations (RR 0.35; 95% CI 0.13 to 0.95). Patients receiving corticosteroids had less need for beta(2)-agonists (mean difference (MD) -3.3 activations/day; 95% CI -5.6 to -1.0). Changes in pulmonary function tests (SMD 0.045; 95% CI -0.47 to 0.56) and side effects (SMD 0.03; 95% CI -0.38 to 0.44) in the first 7 to 10 days, while rarely reported, showed no significant differences between the treatment groups. Statistically significant heterogeneity was identified for the side effect results; all other outcomes were homogeneous. From these results, as few as ten patients need to be treated to prevent relapse to additional care after an exacerbation of asthma. AUTHORS' CONCLUSIONS: A short course of corticosteroids following assessment for an asthma exacerbation significantly reduces the number of relapses to additional care, hospitalizations and use of short-acting beta(2)-agonist without an apparent increase in side effects. Intramuscular and oral corticosteroids are both effective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Why Don't Physicians Follow Clinical Practice Guidelines?: A Framework for Improvement
Cabana, M. D., Rand, C. S., Powe, N. R., Wu, A. W., Wilson, M. H., Abboud, P.-A. C., & Rubin, H. R. (1999) · JAMA · doi:10.1001/jama.282.15.1458 · Cited by 6,677
British Guideline on the Management of Asthma
British Thoracic Society Scottish Intercollegiate Guidelines Network (2008) · Thorax · doi:10.1136/thx.2008.097741 · Cited by 2,021
Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.
Boulet, L. P., Becker, A. B., Bérubé, D., Beveridge, R., & Ernst, P. (1999) · Europe PMC (PubMed Central) · Cited by 536
Glucocorticoids in acute asthma
Fanta, C. H., Rossing, T. H., & McFadden, E. R. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91076-8 · Cited by 262
Asthma attack periodicity: A study of hospital emergency visits in Vancouver
Bates, D. V., Baker-Anderson, M., & Sizto, R. (1990) · Environmental Research · doi:10.1016/s0013-9351(05)80182-3 · Cited by 252
A Controlled Trial of Methylprednisolone in the Emergency Treatment of Acute Asthma
Littenberg, B., & Gluck, E. H. (1986) · New England Journal of Medicine · doi:10.1056/nejm198601163140304 · Cited by 231
Wedzicha, J. A. (2003) · Thorax · doi:10.1136/thorax.58.1.1 · Cited by 227
Chapman, K. R., Verbeek, P. R., White, J. G., & Rebuck, A. S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241202 · Cited by 208
Effectiveness of steroid therapy in acute exacerbations of asthma: A meta-analysis
Rowe, B. H., Keller, J. L., & Oxman, A. D. (1992) · The American Journal of Emergency Medicine · doi:10.1016/0735-6757(92)90007-k · Cited by 208
Self-citationA controlled trial of methylprednisolone in the emergency treatment of acute asthma
(1987) · Journal of Critical Care · doi:10.1016/0883-9441(87)90030-x · Cited by 196
McFadden, E. R., Kiser, R., deGroot, W. J., Holmes, B., Kiker, R., & Viser, G. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90533-7 · Cited by 123
Weber, E. J., Silverman, R. A., Callaham, M. L., et al. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01242-1 · Cited by 105
Zalis, E. G., & PARMLEY, L. F. (1963) · Archives of Internal Medicine · doi:10.1001/archinte.1963.03860060060004 · Cited by 93
Early use of inhaled corticosteroids in the emergency department treatment of acute asthma
Edmonds, M. L., Camargo, C. A., Pollack, C. V., & Rowe, B. H. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002308 · Cited by 89
Self-citationCorticosteroids in acute severe asthma: effectiveness of low doses.
Bowler, S., Mitchell, C. A., & Armstrong, J. G. (1992) · Thorax · doi:10.1136/thx.47.8.584 · Cited by 58
Methylprednisolone pulse therapy in acute severe asthma
Engel, T., Dirksen, A., FRØLUND, L., et al. (1990) · Allergy · doi:10.1111/j.1398-9995.1990.tb00487.x · Cited by 35
Intramuscular methylprednisolone acetate for the prevention of relapse in acute asthma
McNamara, R. M., & Rubin, J. M. (1993) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(05)80409-3 · Cited by 32
Cited by
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
British Guideline on the Management of Asthma
British Thoracic Society Scottish Intercollegiate Guidelines Network (2008) · Thorax · doi:10.1136/thx.2008.097741 · Cited by 2,021
European Resuscitation Council Guidelines for Resuscitation 2015
Perkins, G. D., Handley, A. J., Koster, R. W., Castrén, M., Smyth, M. A., Olasveengen, T., Monsieurs, K. G., Raffay, V., Gräsner, J.-T., Wenzel, V., et al. (2015) · Resuscitation · doi:10.1016/j.resuscitation.2015.07.015 · Cited by 1,287
European Resuscitation Council Guidelines for Resuscitation 2015
Truhlář, A., Deakin, C. D., Soar, J., Khalifa, G. E. A., Alfonzo, A., Bierens, J. J. L. M., Brattebø, G., Brugger, H., Dunning, J., Hunyadi-Antičević, S., et al. (2015) · Resuscitation · doi:10.1016/j.resuscitation.2015.07.017 · Cited by 819
A summary of the new GINA strategy: a roadmap to asthma control
Reddel, H. K., Bateman, E. D., Becker, A., Boulet, L.-P., Cruz, A. A., Drazen, J. M., Haahtela, T., Hurd, S. S., Inoue, H., de Jongste, J. C., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.00853-2015 · Cited by 788
Metadata
- Authors
- Rowe, B. H., Spooner, C., Ducharme, F., Bretzlaff, J., & Bota, G.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2007-07-18
- Volume
- 2008
- Issue
- 4
- Pages
- CD000195-CD000195
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1742527762
- Cited by
- 344
- References
- 19
- FWCI
- 12.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.